Literature DB >> 26280595

Asymmetries of amyloid-β burden and neuronal dysfunction are positively correlated in Alzheimer's disease.

Lars Frings1, Sabine Hellwig2, Timo S Spehl3, Tobias Bormann4, Ralph Buchert5, Werner Vach6, Lora Minkova7, Bernhard Heimbach8, Stefan Klöppel9, Philipp T Meyer3.   

Abstract

Clinical Alzheimer's disease affects both cerebral hemispheres to a similar degree in clinically typical cases. However, in atypical variants like logopenic progressive aphasia, neurodegeneration often presents asymmetrically. Yet, no in vivo imaging study has investigated whether lateralized neurodegeneration corresponds to lateralized amyloid-β burden. Therefore, using combined (11)C-Pittsburgh compound B and (18)F-fluorodeoxyglucose positron emission tomography, we explored whether asymmetric amyloid-β deposition in Alzheimer's disease is associated with asymmetric hypometabolism and clinical symptoms. From our database of patients who underwent positron emission tomography with both (11)C-Pittsburgh compound B and (18)F-fluorodeoxyglucose (n = 132), we included all amyloid-positive patients with prodromal or mild-to-moderate Alzheimer's disease (n = 69). The relationship between (11)C-Pittsburgh compound B binding potential and (18)F-fluorodeoxyglucose uptake was assessed in atlas-based regions of interest covering the entire cerebral cortex. Lateralizations of amyloid-β and hypometabolism were tested for associations with each other and with type and severity of cognitive symptoms. Positive correlations between asymmetries of Pittsburgh compound B binding potential and hypometabolism were detected in 6 of 25 regions (angular gyrus, middle frontal gyrus, middle occipital gyrus, superior parietal gyrus, inferior and middle temporal gyrus), i.e. hypometabolism was more pronounced on the side of greater amyloid-β deposition (range: r = 0.41 to 0.53, all P < 0.001). Stronger leftward asymmetry of amyloid-β deposition was associated with more severe language impairment (P < 0.05), and stronger rightward asymmetry with more severe visuospatial impairment (at trend level, P = 0.073). Similarly, patients with predominance of language deficits showed more left-lateralized amyloid-β burden and hypometabolism than patients with predominant visuospatial impairment and vice versa in several cortical regions. Associations between amyloid-β deposition and hypometabolism or cognitive impairment were predominantly observed in brain regions with high amyloid-β load. The relationship between asymmetries of amyloid-β deposition and hypometabolism in cortical regions with high amyloid-β load is in line with the detrimental effect of amyloid-β burden on neuronal function. Asymmetries were also concordant with lateralized cognitive symptoms, indicating their clinical relevance.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; amyloid; biomarkers; hemispheric differences; positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 26280595     DOI: 10.1093/brain/awv229

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  24 in total

1.  Whole-brain analysis reveals increased neuroanatomical asymmetries in dementia for hippocampus and amygdala.

Authors:  Christian Wachinger; David H Salat; Michael Weiner; Martin Reuter
Journal:  Brain       Date:  2016-10-10       Impact factor: 13.501

2.  Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans.

Authors:  Diego Iacono; Maria Geraci-Erck; Hui Peng; John Paul Bouffard
Journal:  J Vis Exp       Date:  2016-12-18       Impact factor: 1.355

3.  Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.

Authors:  Christine L Tardif; Gabriel A Devenyi; Robert S C Amaral; Sandra Pelleieux; Judes Poirier; Pedro Rosa-Neto; John Breitner; M Mallar Chakravarty
Journal:  Hum Brain Mapp       Date:  2017-11-21       Impact factor: 5.038

4.  Investigating the differential contributions of sex and brain size to gray matter asymmetry.

Authors:  Florian Kurth; Paul M Thompson; Eileen Luders
Journal:  Cortex       Date:  2017-12-06       Impact factor: 4.027

5.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

6.  Using deep Siamese neural networks for detection of brain asymmetries associated with Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Chin-Fu Liu; Shreyas Padhy; Sandhya Ramachandran; Victor X Wang; Andrew Efimov; Alonso Bernal; Linyuan Shi; Marc Vaillant; J Tilak Ratnanather; Andreia V Faria; Brian Caffo; Marilyn Albert; Michael I Miller
Journal:  Magn Reson Imaging       Date:  2019-07-15       Impact factor: 2.546

7.  Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.

Authors:  Lars Frings; Sabine Hellwig; Tobias Bormann; Timo S Spehl; Ralph Buchert; Philipp T Meyer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-15       Impact factor: 9.236

Review 8.  Gray matter asymmetries in aging and neurodegeneration: A review and meta-analysis.

Authors:  Lora Minkova; Annegret Habich; Jessica Peter; Christoph P Kaller; Simon B Eickhoff; Stefan Klöppel
Journal:  Hum Brain Mapp       Date:  2017-08-30       Impact factor: 5.038

Review 9.  18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease.

Authors:  Luca Filippi; Agostino Chiaravalloti; Oreste Bagni; Orazio Schillaci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-08-20

10.  Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration.

Authors:  Ganna Blazhenets; Lars Frings; Yilong Ma; Arnd Sörensen; David Eidelberg; Jens Wiltfang; Philipp T Meyer
Journal:  Neurology       Date:  2021-01-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.